The Heparin/Heparan Sulfate 2-O-Sulfatase from Flavobacterium heparinum
Authors:
- Zachary ShriverZSZachary Shriver
- Chandra ClaycampCCChandra Claycamp
- Maitland W. McLeanMMMaitland W. McLean
- Ganesh VenkataramanGVGanesh Venkataraman
- Ram SasisekharanRSRam Sasisekharan
Open Access
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (14) , 12157-12166
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Roles of heparan-sulphate glycosaminoglycans in cancerNature Reviews Cancer, 2002
- Molecular Cloning of the Heparin/Heparan Sulfate Δ4,5 Unsaturated Glycuronidase from Flavobacterium heparinum, Its Recombinant Expression in Escherichia coli, and Biochemical Determination of Its Unique Substrate SpecificityBiochemistry, 2002
- The Heparin-binding Domain and V Region of Fibronectin Regulate Apoptosis by Suppression of p53 and c-myc in Human Primary CellsJournal of Biological Chemistry, 2002
- Emerging Views of Heparan Sulfate Glycosaminoglycan Structure/Activity Relationships Modulating Dynamic Biological FunctionsTrends in Cardiovascular Medicine, 2002
- Molecular diversity of heparan sulfateJournal of Clinical Investigation, 2001
- Role of heparan sulfate proteoglycans in cell signaling and cancer2001
- Expression of Glycosaminoglycans and Small Proteoglycans in Wounds: Modulation by the Tripeptide–Copper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+Journal of Investigative Dermatology, 2000
- Specificities of heparan sulphate proteoglycans in developmental processesNature, 2000
- Inhibition of glomerular cell apoptosis by heparinKidney International, 1999
- Control of Angiogenesis by Heparin and Other Sulfated Polysaccharides1992